Imran Nasrullah, MS, JD

Imran Nasrullah brings 25 years of business development, licensing, strategy, economic development, and technology transfer experience. He is the VP and Head, Collaborate to Cure Hub – US, Business Development and Licensing at Bayer Pharmaceuticals, where he is responsible for forging new business relationships with academia, industry, and venture capital, which includes mentoring and forming partnerships with early-stage companies. Prior to joining Bayer, Nasrullah had roles at Boehringer Ingelheim, Genzyme Genetics (now LabCorp), Millennium Pharmaceuticals (Takeda), Dana Farber Cancer Center, Mayo Clinic, and MassBio.